Direct link to this page: http://www.hta.ac.uk/1383

Details of HTA journal title

Research type:

NICE Technology Assessment Report (TAR) 

Title (lead author) etc:

Cyclooxygenase-2 selective non-steroidal anti-inflammatory (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis: a systematic review and economic evaluation  (Chen) 178 pages, Volume 12, number 11

Link to NICE guidance page

DOI

10.3310/hta12110
|  View/print executive summary
|  View/print abstract
|  View full text in pdf format (1172 KB)
|  View separate 124 page appendix in pdf format (507 KB)
The appendix is only available electronically. It is not available in the printed version.

| Buy a printed version of this title - cost £20.00 each. [How to order]

# This title is available on our CD-ROM of the journal.
| Order a CD-ROM - free of charge worldwide.


#  Go to our correspondence page to comment on this publication  

This report should be referenced as follows:

Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008;12(11).

Project ref:

03/34/01 

Original project title:

Clinical effectiveness and cost-effectiveness of cyclooxygenase-2 (COX-2) selective inhibitors (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis. 

Chief Investigator:

West Midlands Health Technology Assessment Collaboration (WMHTAC), University of Birmingham  

Start Date:

November 2001  

Date of publication in HTA journal series

April 2008

Cost:

 This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis

MeSH* index primary terms:

OSTEOARTHRITIS Q-drug-therapy; ARTHRITIS-RHEUMATOID Q-drug-therapy; CYCLOOXYGENASE-INHIBITORS Q-therapeutic-use; ANTI-INFLAMMATORY-AGENTS-NON-STEROIDAL Q-therapeutic-use (* = Medical Subject Headings)

MeSH* index secondary terms:

HUMAN  (* = Medical Subject Headings)

NRR* number, if applicable:

N0484131807 (*National Research Register) The National Research Register was a public database of ongoing and recently completed research projects funded by, or of interest to, the United Kingdom's National Health Service (NHS). It is now an archive of projects from early 2000 to September 2007. Search the NRR archive.

Project Protocol:

Project protocol not available

Printed copies of this title despatched:

99 (Figures relate to the previous calendar month)

URL of this page:

http://www.hta.ac.uk/1383
Last updated: 1 February 2012 - Next update due: 8 February 2012

Advanced search How to use the search function